Therefore, considering the direct role of GIP and GLP-1 in adipose tissue, this effect on adipose tissue may also be beneficial in NAFLD; in other words, the tirzepatide may have some indirect effect on the protection of the liver. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.